SHC

Sotera Health Announces Pricing of Secondary Offering

Retrieved on: 
Wednesday, February 28, 2024

CLEVELAND, Feb. 28, 2024 (GLOBE NEWSWIRE) -- Sotera Health Company (Nasdaq: SHC) (the “Company”) today announced the pricing of its secondary offering (the “Offering”) of 25,000,000 shares of its common stock, par value $0.01 per share, at a price to the public of $14.75 per share.

Key Points: 
  • CLEVELAND, Feb. 28, 2024 (GLOBE NEWSWIRE) -- Sotera Health Company (Nasdaq: SHC) (the “Company”) today announced the pricing of its secondary offering (the “Offering”) of 25,000,000 shares of its common stock, par value $0.01 per share, at a price to the public of $14.75 per share.
  • The Company is not offering any shares in the Offering and will not receive any of the proceeds from the Offering.
  • The Company has agreed to pay certain Offering expenses consistent with its obligations under its Amended and Restated Registration Rights Agreement.
  • Barclays, RBC Capital Markets and Santander US Capital Markets LLC are acting as joint book-running managers for the Offering.

Sotera Health Reports Fourth-Quarter and Full-Year 2023 Results; Provides 2024 Outlook

Retrieved on: 
Tuesday, February 27, 2024

2023 net revenues increased 4.5% to $1.05 billion, compared to 2022

Key Points: 
  • 2023 net revenues increased 4.5% to $1.05 billion, compared to 2022
    CLEVELAND, Feb. 27, 2024 (GLOBE NEWSWIRE) -- Sotera Health Company (“Sotera Health” or the “Company”) (Nasdaq: SHC), a leading global provider of mission-critical end-to-end sterilization solutions, lab testing and advisory services for the healthcare industry, today announced financial results for the fourth-quarter and full-year 2023 and its initial 2024 outlook.
  • For the fourth-quarter 2023, net revenues increased 23.3% to $310 million, compared with $252 million in the same period a year ago.
  • For full-year 2023, net revenues increased 4.5% to $1.05 billion, compared with $1.00 billion for full-year 2022.
  • Updates on recent developments in matters relevant to investors can be found on the Investor Relations section of the Sotera Health website at Investor Relations | Sotera Health .

Four Hackensack Meridian Health Hospitals First in Nation to Achieve The Joint Commission's Sustainable Healthcare Certification

Retrieved on: 
Wednesday, March 6, 2024

OAKBROOK TERRACE, Ill. and EDISON, N.J., March 6, 2024 /PRNewswire/ -- Four hospitals within Hackensack Meridian Health, New Jersey's largest and most integrated health network, are first in the nation to achieve The Joint Commission's Sustainable Healthcare Certification (SHC).

Key Points: 
  • OAKBROOK TERRACE, Ill. and EDISON, N.J., March 6, 2024 /PRNewswire/ -- Four hospitals within Hackensack Meridian Health, New Jersey's largest and most integrated health network, are first in the nation to achieve The Joint Commission's Sustainable Healthcare Certification (SHC).
  • "We are incredibly proud to be the first hospital network in the nation to receive The Joint Commission's Sustainable Healthcare Certification," said Robert C. Garrett, FACHE, CEO of Hackensack Meridian Health.
  • Four of its hospitals were among the first in the nation to achieve The Joint Commission's Healthcare Equity Certification in late 2023.
  • "Achieving The Joint Commission's Healthcare Equity Certification and Sustainable Healthcare Certification demonstrate Hackensack Meridian Health's leadership role and commitment toward responsible and ethical practices."

ASA National Staffing Employee of the Year, Dr. Kelly Byrd, Featured in Staffing Success Magazine

Retrieved on: 
Monday, February 26, 2024

Now, SHC is excited to share her feature in the January/February issue of ASA's Staffing Success Magazine .

Key Points: 
  • Now, SHC is excited to share her feature in the January/February issue of ASA's Staffing Success Magazine .
  • Through her work with SHC, Dr. Byrd has been able to pursue her passion and make a difference in the lives of children.
  • Dr. Byrd has been a dedicated school speech-language pathologist and advocate for family literacy while working with Supplemental Health Care for over a decade.
  • As Riddle shared: "Kelly is a perfect example of the flexibility the staffing industry provides that the regular work world doesn't.

SIA Staffing 100 List: Kelly Mahannah, President of Workforce Solutions Recognized

Retrieved on: 
Tuesday, February 20, 2024

SALT LAKE CITY, Feb. 20, 2024 /PRNewswire/ -- Supplemental Health Care (SHC) is pleased to announce that President of Workforce Solutions, Kelly Mahannah, has been named to the Staffing Industry Analysts (SIA) Staffing 100 list this year.

Key Points: 
  • SALT LAKE CITY, Feb. 20, 2024 /PRNewswire/ -- Supplemental Health Care (SHC) is pleased to announce that President of Workforce Solutions, Kelly Mahannah, has been named to the Staffing Industry Analysts (SIA) Staffing 100 list this year.
  • Part of the SHC team since 2018 and named President of Workforce Solutions in 2022, Mahannah has been instrumental in tripling the company's managed service provider (MSP) footprint.
  • Despite the challenges of the COVID-19 pandemic, she led SHC to onboard multiple large health systems while simultaneously filling critical care team roles for existing partners.
  • "SHC was one of the few MSP program providers that met all of their healthcare client's staffing needs during the pandemic," Mahannah explains.

Sotera Health Announces Fourth-Quarter and Full-Year 2023 Earnings Release Date

Retrieved on: 
Thursday, February 15, 2024

Following the release, management will hold a conference call at 9:00 a.m. Eastern Time to discuss the Company’s operating highlights and financial results.

Key Points: 
  • Following the release, management will hold a conference call at 9:00 a.m. Eastern Time to discuss the Company’s operating highlights and financial results.
  • A live webcast of the conference call can be accessed at this link or via the Investor Relations section of the Company’s website at Presentation & Events | Sotera Health , along with the accompanying materials.
  • Updates can be found from time to time on recent developments in matters relevant to investors on the Investor Relations section of the Company’s website at Investor Relations | Sotera Health .
  • For developments related to Ethylene Oxide, updates can be found at Ethylene Oxide | Sotera Health .

INVESTIGATION ALERT: Kaskela Law LLC Announces Shareholder Investigation of Sotera Health Co. (NASDAQ: SHC) and Encourages Long-Term Investors to Contact the Firm

Retrieved on: 
Wednesday, February 14, 2024

PHILADELPHIA, Feb. 14, 2024 (GLOBE NEWSWIRE) -- Kaskela Law LLC announces that it has commenced an investigation into Sotera Health Company (NASDAQ: SHC) (“Sotera”) on behalf of the company’s long-term investors.

Key Points: 
  • PHILADELPHIA, Feb. 14, 2024 (GLOBE NEWSWIRE) -- Kaskela Law LLC announces that it has commenced an investigation into Sotera Health Company (NASDAQ: SHC) (“Sotera”) on behalf of the company’s long-term investors.
  • Recently an amended securities fraud complaint was filed against Sotera on behalf of certain investors who purchased shares of the company’s stock between November 19, 2020 and September 19, 2022.
  • Sotera shareholders who purchased or acquired their shares prior to September 19, 2022 are encouraged to contact Kaskela Law LLC (D. Seamus Kaskela, Esq.
  • Kaskela Law LLC exclusively represents investors in securities fraud, corporate governance, and merger & acquisition litigation.

Another Best of Staffing Client and Talent Win for Supplemental Health Care in 2024

Retrieved on: 
Tuesday, February 6, 2024

SALT LAKE CITY, Feb. 6, 2024 /PRNewswire/ -- ClearlyRated announced today that Supplemental Health Care (SHC) has won the Best of Staffing Client and Talent awards for providing superior service for a seventh year in a row.

Key Points: 
  • SALT LAKE CITY, Feb. 6, 2024 /PRNewswire/ -- ClearlyRated announced today that Supplemental Health Care (SHC) has won the Best of Staffing Client and Talent awards for providing superior service for a seventh year in a row.
  • Presented in partnership with Gold Sponsor ClearEdge Marketing, ClearlyRated's Best of Staffing Award winners are industry leaders in service quality based on ratings provided by their working talent and client partners.
  • "I'm so excited to introduce the 2024 Best of Staffing winners," said ClearlyRated's CEO, Eric Gregg.
  • Additionally, the Best of Staffing Client Award winner received an NPS of 68.1 percent, which was significantly higher than the industry average of 36 percent in 2023.

Sotera Health Chairman and CEO Presents at 42nd Annual J.P. Morgan Healthcare Conference

Retrieved on: 
Tuesday, January 9, 2024

CLEVELAND, Jan. 09, 2024 (GLOBE NEWSWIRE) -- Sotera Health Company (“Sotera Health” or the “Company”) (Nasdaq: SHC), a leading global provider of mission-critical end-to-end sterilization solutions and lab testing and advisory services for the healthcare industry, is presenting today at the 42nd Annual J.P. Morgan Healthcare Conference.

Key Points: 
  • CLEVELAND, Jan. 09, 2024 (GLOBE NEWSWIRE) -- Sotera Health Company (“Sotera Health” or the “Company”) (Nasdaq: SHC), a leading global provider of mission-critical end-to-end sterilization solutions and lab testing and advisory services for the healthcare industry, is presenting today at the 42nd Annual J.P. Morgan Healthcare Conference.
  • During the presentation, Chairman and CEO Michael B. Petras, Jr. will be providing an update on Sotera Health’s business.
  • “I am pleased to announce that Sotera Health delivered top-line growth in 2023 despite an ongoing challenging environment,” said Mr. Petras.
  • The consistent growth we have demonstrated since going public in 2020 reinforces the criticality of Sotera Health’s role in global healthcare and the Company’s durable business model.

Sotera Health to Present at the 42nd Annual J.P. Morgan Healthcare Conference

Retrieved on: 
Wednesday, January 3, 2024

CLEVELAND, Jan. 03, 2024 (GLOBE NEWSWIRE) -- Sotera Health Company (“Sotera Health” or the “Company”) (NASDAQ: SHC), a leading global provider of mission-critical end-to-end sterilization solutions, lab testing and advisory services for the healthcare industry, today announced that Chairman and CEO Michael B. Petras, Jr. will present at the 42nd Annual J.P. Morgan Healthcare Conference on Tuesday, January 9, 2024 at 5:15 pm Eastern.

Key Points: 
  • CLEVELAND, Jan. 03, 2024 (GLOBE NEWSWIRE) -- Sotera Health Company (“Sotera Health” or the “Company”) (NASDAQ: SHC), a leading global provider of mission-critical end-to-end sterilization solutions, lab testing and advisory services for the healthcare industry, today announced that Chairman and CEO Michael B. Petras, Jr. will present at the 42nd Annual J.P. Morgan Healthcare Conference on Tuesday, January 9, 2024 at 5:15 pm Eastern.
  • Mr. Petras, Jon Lyons, Senior Vice President and CFO, and Jason Peterson, Vice President and Treasurer, will participate in meetings with investors during the conference.
  • A live webcast of Mr. Petras’ presentation and accompanying materials may be accessed via the Investor Relations section of the Company’s website at Presentation & Events | Sotera Health .
  • A replay of the webcast will be archived on the Company's website.